Clinical Trial Update: A Study of Pembrolizumab (MK-3475) Versus Paclitaxel, Docetaxel, or Vinflunine for Participants With Advanced Urothelial Cancer (MK-3475-045/KEYNOTE-045) [Phase 3]

View source ↗

Summary

Phase 3 trial comparing pembrolizumab to chemotherapy for advanced urothelial cancer has completed with posted results in 2017.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Urothelial Cancer

Drugs mentioned

• DOCETAXEL (DOCETAXEL)
• PACLITAXEL (PACLITAXEL)
• Pembrolizumab (pembrolizumab)
• Vinflunine (vinflunine)

Snippet

Sponsor: Merck Sharp & Dohme LLC | Conditions: Urothelial Cancer | Phase 3 | Status: COMPLETED | Results posted: 2017-08-31